LEGN Form 144 Filed for 1,000 American Depositary Shares Sale
Rhea-AI Filing Summary
Form 144 notice for Legend Biotech Corp (LEGN) reports a proposed sale of 1,000 American Depositary Shares through Fidelity Brokerage Services with an aggregate market value of $33,285 and an approximate sale date of 09/26/2025 on NASDAQ. The shares were acquired on 06/20/2022 as restricted stock vesting from the issuer and were paid as compensation. The filing lists 367,298,315 shares outstanding for the class and discloses a prior sale by Patrick Casey of 1,000 ADS on 06/26/2025 for $33,234. The filer signs the required representation that they are unaware of material nonpublic information.
Positive
- Full Rule 144 disclosure provided including broker, acquisition details, and prior three-month sale
- Securities were acquired via restricted stock vesting, clearly stated as compensation
Negative
- Insider sale occurred: prior sale of 1,000 ADS on 06/26/2025 is disclosed
Insights
TL;DR: Routine Rule 144 disclosure of an insider sale; filing documents acquisition source and recent sale, satisfying disclosure requirements.
The Form 144 provides the standard items required under Rule 144: identity of broker, number of ADS to be sold, aggregate market value, acquisition date and nature of acquisition, and a prior sale within the three-month lookback period. The filing explicitly states the shares were acquired via restricted stock vesting on 06/20/2022 and identifies the prior sale on 06/26/2025. From a compliance perspective, the document appears complete for a notice of proposed sale and includes the attestation regarding material nonpublic information. No regulatory exceptions or special conditions are disclosed in the filing.
TL;DR: Insiders disclosed a small sale of 1,000 ADS; the item is a routine liquidity event with limited apparent market impact.
The notice shows an insider intends to sell 1,000 American Depositary Shares via Fidelity with an indicated aggregate market value of $33,285. The shares were granted through restricted stock vesting and treated as compensation. The filing also records a previous sale of 1,000 ADS on 06/26/2025 for $33,234. The information supplied is factual and concise; it does not include company financials or forward-looking statements, so its informational impact on the broader investment case is limited based on the filing contents alone.
FAQ
What does the Form 144 filed for LEGN disclose?
When and how were the shares being sold acquired?
Is there any recent prior sale by the same person disclosed?
On which exchange is the proposed sale expected to occur?
How many shares outstanding does the filing list for the class?